An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

BACKGROUND: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatment, alternative therapies are often offered to patients. The aim of this study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Péron, Julien, Polivka, Valentine, Chabaud, Sylvie, Poupart, Marc, Ceruse, Philippe, Ramade, Antoine, Girodet, Didier, Zrounba, Philippe, Fayette, Jérôme
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4096421/
https://ncbi.nlm.nih.gov/pubmed/25011678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-504
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados